Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality

Background Identification of lifestyle modifiable metabolic pathways related to cardiometabolic disease risk is essential for improvement of primary prevention in susceptible individuals. It was recently shown that plasma dimethylguanidino valerate (DMGV) levels are associated with incident type 2 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Filip Ottosson, Ulrika Ericson, Peter Almgren, Einar Smith, Louise Brunkwall, Sophie Hellstrand, Peter M. Nilsson, Marju Orho‐Melander, Céline Fernandez, Olle Melander
Formato: Artículo
Lenguaje:English
Publicado: Wiley 2019-10-01
Colección:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Materias:
Acceso en línea:https://www.ahajournals.org/doi/10.1161/JAHA.119.012846